WebOct 17, 2016 · The SEER-Medicare linked data combine information from the SEER cancer registries data with Medicare enrollment and claims data. The SEER-Medicare data includes two cohorts: Medicare enrollees who linked to a SEER cancer record. A non-cancer control population of Medicare beneficiaries who are residents of the SEER areas, but did not link … WebNCI periodically offers SEER-Medicare training for researchers interested in learning more about these data. Information about upcoming training workshops will be posted as available on the SEER-Medicare home page under "Announcements". Copies of the slides from the training sessions can be obtained upon request. August 2024.

美国seer数据库怎么用？ - 知乎

Web我们从 SEER-Medicare 数据集中确定了 2011 年 1 月 1 日至 2015 年 12 月 31 日期间诊断为任何阶段 NSCLC 的患者，这些患者接受了适合阶段的治疗，并在诊断后 1 年内进行了计算机断层扫描。确认时间被确定为最近的计算机断层扫描成像和组织学诊断日期之间的间隔。 WebDec 20, 2024 · SEER-Medicare: Requirements of Investigators Following Receipt of the Data. Investigators who have received the SEER-Medicare data must abide by the policies established by NCI and the SEER program. These include the following: Researchers must send a copy of any manuscript or book chapter to the SEER-Medicare contact prior to … i hope you had a safe trip back

JAMA Oncology长文 专家综述比SEER数据库大3倍的数据库 - 简书

Webunderstood. Thus, we utilized the Surveillance, Epidemiology, and End Results (SEER)-Medicare resource to examine risk factors and novel preexisting medical conditions that may be associated with these cancer types. Methods Between 2000 and 2011, 2,092 ICC and 2,981 ECC cases and 323,615 controls were iden-tified using the SEER-Medicare … WebMar 18, 2024 · The SEER-Medicare database is sponsored by the National Cancer Institute and aggregates data from 18 defined geographic areas with 98% case ascertainment. 10 The study was deemed exempt from review by the institutional review board of the University of Texas Medical Branch, and informed consent was waived because of the … WebFirst, our study uses SEER-Medicare data for the period 1996 to 2013, and thus we were able to adjust for some of the clinical variable such as cancer grade at the time of diagnosis. Second, taking advantage of the availability of long-term follow-up data, our cohort consisted of prostate cancer patients receiving androgen deprivation therapy ... i hope you had a nice trip back home